MODD vs. PROF, INFU, TLSI, ZJYL, SGHT, LNSR, HYPR, ECOR, PDEX, and TELA
Should you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include Profound Medical (PROF), InfuSystem (INFU), TriSalus Life Sciences (TLSI), Jin Medical International (ZJYL), Sight Sciences (SGHT), LENSAR (LNSR), Hyperfine (HYPR), electroCore (ECOR), Pro-Dex (PDEX), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry.
Modular Medical vs.
Modular Medical (NASDAQ:MODD) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.
Modular Medical presently has a consensus target price of $5.00, indicating a potential upside of 358.72%. Profound Medical has a consensus target price of $14.25, indicating a potential upside of 90.51%. Given Modular Medical's higher possible upside, analysts plainly believe Modular Medical is more favorable than Profound Medical.
Modular Medical has higher earnings, but lower revenue than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.
Modular Medical has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. Profound Medical's return on equity of -85.22% beat Modular Medical's return on equity.
27.5% of Modular Medical shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 20.5% of Modular Medical shares are held by company insiders. Comparatively, 1.5% of Profound Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Profound Medical had 9 more articles in the media than Modular Medical. MarketBeat recorded 9 mentions for Profound Medical and 0 mentions for Modular Medical. Profound Medical's average media sentiment score of 1.12 beat Modular Medical's score of 0.00 indicating that Profound Medical is being referred to more favorably in the news media.
Profound Medical received 38 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 72.73% of users gave Profound Medical an outperform vote.
Modular Medical has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.
Summary
Profound Medical beats Modular Medical on 11 of the 18 factors compared between the two stocks.
Get Modular Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Modular Medical Competitors List
Related Companies and Tools
This page (NASDAQ:MODD) was last updated on 2/22/2025 by MarketBeat.com Staff
Free MODD Stock Alerts